WLKP · Westlake Chemical Partners LP - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · WLKP

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$1.17B	$1.14B	$1.19B	$1.59B	$1.21B	$966.67M
Cost of Revenue	$818.85M	$716.96M	$803.33M	$1.22B	$773.15M	$587.79M
Gross Profit	$347.85M	$418.94M	$387.46M	$377.37M	$441.71M	$378.88M
R&D	-	-	-	-	-	-
SG&A	$28.27M	$28.50M	$29.75M	$29.68M	$31.02M	$25.89M
Total Operating Expenses	-	-	-	-	-	-
D&A	$127.98M	$111.90M	$110.20M	$121.07M	$108.81M	$103.15M
Operating Income	$319.58M	$390.44M	$357.71M	$347.69M	$410.69M	$352.99M
Interest Expense	$22.90M	$25.70M	$26.50M◇	$13.41M◇	$8.82M◇	-
Income Tax	$547.0K	$835.0K	$813.0K	$1.02M	$549.0K	$564.0K
Net Income	$48.70M	$62.39M	$54.28M	$64.17M	$82.55M	$66.17M
EPS - Basic	-	-	-	-	-	-
EPS - Diluted	-	-	-	-	-	-

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$44.27M	$58.32M	$58.62M	$64.78M	$17.06M	$17.15M
Accounts Receivable	$9.11M	$11.58M	$18.70M	$20.03M	$5.83M	$11.03M
Inventory	$2.77M	$4.06M	$4.43M	$4.71M	$8.90M	$3.47M
Accounts Payable	-	-	-	$15.32M	$35.10M	$13.13M
Current Assets	$143.51M	$240.93M	$226.20M	$245.79M	$281.21M	$263.31M
Total Assets	$1.26B	$1.29B	$1.32B	$1.37B	$1.48B	$1.36B
Current Liabilities	$51.30M	$55.37M	$56.34M	$66.94M	$106.80M	$39.75M
Long-term Debt	-	-	-	-	-	-
Total Liabilities	$454.18M	$458.64M	$460.59M	$468.27M	$508.00M	$441.35M
Stockholders' Equity	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-	-

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$280.47M	$485.00M	$452.00M	$463.74M	$408.44M	$373.40M
Investing Cash Flow	$31.18M	($88.97M)	($75.94M)	($12.00M)	($64.30M)	$2.03M
Financing Cash Flow	($325.70M)	($396.33M)	($382.23M)	($404.01M)	($344.24M)	($378.20M)
CapEx	$78.82M	$48.97M	$46.82M	$54.12M	$81.17M	$36.97M
Free Cash Flow	$201.65M	$436.03M	$405.18M	$409.62M	$327.27M	$336.43M

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	29.8%	36.9%	32.5%	23.7%	36.4%	39.2%
Operating margin	27.4%	34.4%	30.0%	21.8%	33.8%	36.5%
EBITDA margin	38.4%	44.2%	39.3%	29.4%	42.8%	47.2%
Net margin	4.2%	5.5%	4.6%	4.0%	6.8%	6.8%
Free cash flow margin	17.3%	38.4%	34.0%	25.7%	26.9%	34.8%
FCF / Net income	4.14	6.99	7.46	6.38	3.96	5.08
R&D / Revenue	-	-	-	-	-	-
SG&A / Revenue	2.4%	2.5%	2.5%	1.9%	2.6%	2.7%
Effective tax rate	1.1%	1.3%	1.5%	1.6%	0.7%	0.8%
Return on assets	3.9%	4.8%	4.1%	4.7%	5.6%	4.9%
Return on equity	-	-	-	-	-	-
Return on invested capital	-	-	-	-	-	-
Liquidity
Current ratio	2.80	4.35	4.02	3.67	2.63	6.62
Quick ratio	2.74	4.28	3.94	3.60	2.55	6.54
Cash ratio	0.86	1.05	1.04	0.97	0.16	0.43
Leverage
Debt / Equity	-	-	-	-	-	-
Debt / Assets	-	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-	-
Interest coverage	14.0x	15.2x	13.5x	25.9x	46.6x	-
Equity multiplier	-	-	-	-	-	-
Liabilities / Assets	0.36	0.36	0.35	0.34	0.34	0.33
Efficiency
Asset turnover	0.93	0.88	0.90	1.16	0.82	0.71
Inventory turnover	295.72	176.68	181.26	257.85	86.89	169.20
Days sales outstanding	3d	4d	6d	5d	2d	4d
Days inventory outstanding	1d	2d	2d	1d	4d	2d
Days payable outstanding	-	-	-	5d	17d	8d
Cash conversion cycle	-	-	-	1d	-11d	-2d
Valuation
P / E	-	-	-	-	-	-
P / B	-	-	-	-	-	-
P / S	-	-	-	-	-	-
EV / EBITDA	-	-	-	-	-	-
Growth
Revenue growth (YoY)	2.7%	-4.6%	-25.3%	31.1%	25.7%	-11.5%
Revenue CAGR (3y)	-9.9%	-2.2%	7.2%	13.4%	7.2%	-6.2%
Revenue CAGR (5y)	3.8%	0.8%	3.8%	6.3%	4.2%	-0.8%
Gross profit growth (YoY)	-17.0%	8.1%	2.7%	-14.6%	16.6%	-0.1%
Operating income growth (YoY)	-18.2%	9.2%	2.9%	-15.3%	16.3%	0.8%
Net income growth (YoY)	-21.9%	14.9%	-15.4%	-22.3%	24.8%	8.5%
EPS growth (YoY)	-	-	-	-	-	-
EPS CAGR (3y)	-	-	-	-	-	-
EPS CAGR (5y)	-	-	-	-	-	-
FCF growth (YoY)	-53.8%	7.6%	-1.1%	25.2%	-2.7%	-17.4%
FCF CAGR (5y)	-9.7%	1.4%	0.4%	-2.7%	-	8.7%
Book value growth (YoY)	-	-	-	-	-	-

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2020-12-31.

Product / service

$78.42M total

Product And Service Other$78.42M · 100.0%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

4/9

Neutral

✓Net income positive
✓Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
-Long-term debt decreased
✗Current ratio improved
-No share dilution
✗Gross margin improved
✓Asset turnover improved

Peer comparison

Same SIC group: Industrial Organic Chemicals

Company	Revenue (last FY)	Net margin	ROE
LYB	$30.15B	-2.4%	-7.3%
IFF	$10.89B	-3.3%	-2.6%
SXT	$1.61B	8.3%	11.3%
WLK	$11.17B	-13.5%	-17.2%
GEVO	$160.58M	-21.1%	-7.3%

Comparing Westlake Chemical Partners LP against the 5 most active filers in the same SIC group.

Dividends

$1.88/share trailing 12 months · 0.0% YoY

Ex-date	Per share
May 14, 2026	$0.4710
Feb 6, 2026	$0.4710
Nov 10, 2025	$0.4710
Aug 12, 2025	$0.4710
May 13, 2025	$0.4710
Feb 7, 2025	$0.4710
Nov 12, 2024	$0.4710
Aug 12, 2024	$0.4710
May 10, 2024	$0.4710
Feb 1, 2024	$0.4710
Nov 9, 2023	$0.4710
Aug 10, 2023	$0.4710
May 11, 2023	$0.4710
Feb 1, 2023	$0.4710
Nov 9, 2022	$0.4710
Aug 10, 2022	$0.4710
May 11, 2022	$0.4710
Feb 2, 2022	$0.4710
Nov 10, 2021	$0.4710
Aug 11, 2021	$0.4710
May 12, 2021	$0.4710
Feb 3, 2021	$0.4710
Nov 6, 2020	$0.4710
Aug 7, 2020	$0.4710

Cells marked with a small ◇ are sourced from SEC's bulk Financial Statement Data Sets, which can lose dimensional context (notably Revenue and Operating Income for issuers that report by segment). These cells will be replaced with authoritative values from the Company Facts API as the backfill completes.